Healthcare company-building profile
IndieBio New York (now SOSV NY)
SOSV
AcceleratorVC-backed programInvestor backedActive
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- VC-backed program
- Organization
- SOSV
- Organization type
- Investor backed
- Location
- New York, New York
- Company stage served
- Pre-seed to Seed
- Cohort or participation model
- Not publicly documented
- Investment or funding offered
- Not publicly documented
- Published investment terms
- Not publicly documented
- Equity or fee model
- Not publicly documented
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
- Founded
- 2019
Public description
About the program
SOSV launched IndieBio New York as a second US site for its biology accelerator, giving East Coast scientist-founders lab access and pre-seed capital on a cohort schedule. It runs the same investment-plus-bench model as the San Francisco program. The program was renamed SOSV NY in March 2026 as part of a broader SOSV deep-tech rebrand.
What the program publicly emphasizes
Focus areas and features
BiotechTherapeuticsSynthetic biologyClimate biotechDeep tech
- Category: VC-backed program
Sources
External source links open in a new tab.